. .
.
. Mayo Clinic Health Solutions
.
. .
.

Browse Categories:
  arrow Research Tools
arrow
  arrow Diagnostics
arrow
  arrow Therapeutics
arrow
  arrow Medical Devices
arrow
  arrow Electronic Devices
arrow
  arrow Software
arrow
  arrow All Listings
arrow
arrow
  Home
arrow
  About Us
arrow
  Contact Us
arrow
arrow
  Go to mayoclinic.org
arrow
  Go to Research at Mayo Clinic
arrow
Mayo Clinic Technology
.

Inducible Tau Mice Expressing Human 4RON Tau With the P301L Mutation (termed iP301L)

Reference #:

2008-163

Inventors/Contributors

Jada M. Lewis, Ph.D.

Description

These mice conditionally express the human tau cDNA (4RON isoform) containing the FTDP-17 mutation (P301L) in exon 10. These mice utilize the tet-off system to express approximately 7X human tau in comparison to murine tau. Both the tTA transgene (Memory Pharmaceuticals) and the tau transgene (Mayo) must be present to yield expression of the human tau. Doxycycline in the diet of the mice repressed the human tau transgene. These mice develop pre-tangle pathology at approximately 12-15M and tangle pathology and neuronal loss by 20-24M. This is a good model of tauopathy in which to investigate factors which may accelerate tauopathy. It is a complementary model to rTg4510.

Patent Status

None

Contact

Susan L. Stoddard, Ph.D., Licensing Manager
sstoddard@mayo.edu

Mayo Foundation for Medical Education and Research
Office of Technology Commercialization
MN BioBusiness Center
200 First Street SW
Rochester, MN 55905

Phone: (507) 284-1222
Fax: (507) 284-5410